How chronic stress accelerates Alzheimer's disease

March 14, 2013
The figure shows the proportion of AD mice with normal and impaired memory in each treatment group respectively. A substantial increase in the number of mice with impaired memory function was found after chronically elevated levels of allopregnanolone in comparison to placebo treatment.

Why does chronic stress lead to increased risk for dementia? The answer may lie in the elevation of stress steroids that is seen in the brain during stress, Sara K. Bengtsson suggests in the thesis she is defending at Umeå University in Sweden on March 22.

These stress steroids can inhibit the general brain activity. Allopregnanolon is one of them, and the doctoral thesis shows that chronically elevated levels of allopregnanolone accelerated the disease development in two transgenic Alzheimer . The Alzheimer mice responded with impaired learning and memory. They had also increased brain levels of beta-amyloids, i.e. the proteins that form plaques in Alzheimer's disease.

The thesis also demonstrates that high levels of beta-amyloids corresponded to dysfunction among brain synapses. This was seen after a period of chronically elevated levels of allopregnanolon, but not after . The effects were identified early in the disease development when the animals normally have intact memory function. A similar acceleration of AD in humans could mean the difference between living self-sufficiently at home and living with requirements of professional care.

Sara K. Bengtsson was born in Malmö, Sweden, and completed her pre-university graduation in Ystad. Professionally, Sara K. Bengtsson has worked in various fields and in 2008 she completed her Master's degree in medicine with a major in biomedicine at Umeå University, Sweden, where she now is a postgraduate student at the Department of Clinical Sciences, division of .

On Friday, March 22nd, Sara K. Bengtsson, Department of Clinical Sciences, Umeå University, is publicly defending her thesis with the title "Stress steroids as accelerators of Alzheimer's disease." Effects of chronically elevated levels of allopregnanolone in transgenic AD models.

Explore further: Scientists study link between amyloid beta peptide levels and Alzheimer's disease

More information: Read the thesis or abstract at: urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-66572

Related Stories

Clue to cause of Alzheimer's dementia found in brain samples

October 22, 2012

Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer's disease and those who are cognitively normal but still have brain plaques that characterize ...

Recommended for you

Alzheimer's stemmed but not stopped, say experts

September 19, 2016

Soaring rates of population growth and ageing have long been seen as portending a global explosion of Alzheimer's, the debilitating disease that robs older people of their memory and independence.

Memory loss not enough to diagnose Alzheimer's

September 13, 2016

Relying on clinical symptoms of memory loss to diagnose Alzheimer's disease may miss other forms of dementia caused by Alzheimer's that don't initially affect memory, reports a new Northwestern Medicine study.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.